Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Depreciation & Amortization (CF) (2016 - 2026)

Healthequity (HQY) has 13 years of Depreciation & Amortization (CF) data on record, last reported at $38.8 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 4.77% year-over-year to $38.8 million; the TTM value through Oct 2025 reached $155.2 million, down 3.74%, while the annual FY2025 figure was $162.5 million, 6.12% up from the prior year.
  • Depreciation & Amortization (CF) reached $38.8 million in Q4 2025 per HQY's latest filing, up from $38.5 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $43.6 million in Q3 2024 and bottomed at $30.4 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $38.0 million, with a median of $38.8 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): rose 27.63% in 2022, then fell 11.82% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $33.5 million in 2021, then grew by 20.73% to $40.5 million in 2022, then fell by 6.72% to $37.8 million in 2023, then increased by 7.78% to $40.7 million in 2024, then decreased by 4.77% to $38.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $38.8 million in Q4 2025, $38.5 million in Q3 2025, and $38.7 million in Q2 2025.